Christoforos Vaxevanis
Overview
Explore the profile of Christoforos Vaxevanis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vaxevanis C, Bachmann M, Seliger B
J Immunother Cancer
. 2024 Aug;
12(8).
PMID: 39209767
The importance of the immune system in regulating tumor growth by inducing immune cell-mediated cytotoxicity associated with patients' outcomes has been highlighted in the past years by an increasing life...
2.
Blumke J, Bauer M, Vaxevanis C, Wilfer A, Mandelboim O, Wickenhauser C, et al.
Oncoimmunology
. 2023 Dec;
12(1):2284483.
PMID: 38126030
The human Epstein-Barr virus (EBV), as a member of the human γ herpes viruses (HHV), is known to be linked with distinct tumor types. It is a double-stranded DNA virus...
3.
Schafer H, Subbarayan K, Massa C, Vaxevanis C, Mueller A, Seliger B
J Transl Med
. 2023 Sep;
21(1):643.
PMID: 37730606
Background: Despite immunotherapies having revolutionized the treatment of advanced cutaneous melanoma, effective and durable responses were only reported in a few patients. A better understanding of the interaction of melanoma...
4.
Bauer M, Vaxevanis C, Al-Ali H, Jaekel N, Naumann C, Schaffrath J, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33430322
: Myelodysplastic syndromes (MDS) are caused by a stem cell failure and often include a dysfunction of the immune system. However, the relationship between spatial immune cell distribution within the...
5.
Bauer M, Vaxevanis C, Heimer N, Al-Ali H, Jaekel N, Bachmann M, et al.
Int J Mol Sci
. 2020 Sep;
21(19).
PMID: 32992663
Myelodysplastic syndromes (MDS), heterogeneous diseases of hematopoietic stem cells, exhibit a significant risk of progression to secondary acute myeloid leukemia (sAML) that are typically accompanied by MDS-related changes and therefore...
6.
Friedrich M, Lazaridou M, Rahn J, Vaxevanis C, Heimer N, Jasinski-Bergner S, et al.
Methods Enzymol
. 2020 Mar;
636:339-350.
PMID: 32178825
By binding RNA in a sequence- and/or structure-dependent manner, RNA-binding proteins (RBPs) and their target RNA form a ribonucleoprotein complex involved in the RNA's fate. In this context, RBPs were...
7.
Jasinski-Bergner S, Vaxevanis C, Heimer N, Lazaridou M, Friedrich M, Seliger B
Methods Enzymol
. 2020 Mar;
636:323-337.
PMID: 32178824
The major mechanisms of posttranscriptional gene regulation involve microRNAs (miRs) and RNA-binding proteins (RBPs). Recent studies not only identified functionally and characterized such factors, but rather investigated their use as...
8.
Bauer M, Vaxevanis C, Bethmann D, Massa C, Pazaitis N, Wickenhauser C, et al.
Methods Enzymol
. 2020 Mar;
635:67-79.
PMID: 32122554
Immunohistochemistry (IHC) using specific antibodies is a well-established method for the visualization of distinct cell populations. With increasing availability of suitable methods for complex tissue analyses, new demands have arisen...
9.
Tretbar S, Krausbeck P, Muller A, Friedrich M, Vaxevanis C, Bukur J, et al.
Oncotarget
. 2019 Mar;
10(15):1507-1524.
PMID: 30863498
Epithelial-to-mesenchymal transition (EMT) is a crucial step in cancer progression and the number one reason for poor prognosis and worse overall survival of patients. Although this essential process has been...